Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial.
about
Sniff nasal inspiratory pressure does not decrease in elderly subjectsSafety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.Pattern of Respiratory Deterioration in Sporadic Amyotrophic Lateral Sclerosis According to Onset Lesion by Using Respiratory Function TestsPhrenic nerve conduction studies as a biomarker of respiratory insufficiency in amyotrophic lateral sclerosis.Correlation between Forced Vital Capacity and Slow Vital Capacity for the assessment of respiratory involvement in Amyotrophic Lateral Sclerosis: a prospective study.Multiparametric Analysis of Sniff Nasal Inspiratory Pressure Test in Middle Stage Amyotrophic Lateral Sclerosis.
P2860
Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Limitations of sniff nasal pre ...... patients in a clinical trial.
@en
Limitations of sniff nasal pre ...... patients in a clinical trial.
@nl
type
label
Limitations of sniff nasal pre ...... patients in a clinical trial.
@en
Limitations of sniff nasal pre ...... patients in a clinical trial.
@nl
prefLabel
Limitations of sniff nasal pre ...... patients in a clinical trial.
@en
Limitations of sniff nasal pre ...... patients in a clinical trial.
@nl
P2093
P2860
P356
P1433
P1476
Limitations of sniff nasal pre ...... patients in a clinical trial.
@en
P2093
P2860
P304
P356
10.1159/000339415
P577
2012-07-28T00:00:00Z